Table 2.

HR for all-cause death and cardiovascular outcomes in relation to quartiles of hs-cTnI in the whole cohort.a

OutcomeHR (95% CI), adjusted aHR (95% CI), adjusted b
All-cause death
    Quartile 1ReferentReferent
    Quartile 21.41 (1.22–1.63)**b1.40 (1.20–1.62)**
    Quartile 31.62 (1.41–1.87)**1.55 (1.33–1.79)**
    Quartile 42.31 (2.01–2.67)**2.07 (1.78–2.40)**
Incidence of CVDs
    Quartile 1ReferentReferent
    Quartile 21.44 (1.18–1.77)**1.32 (1.07–1.61)
    Quartile 31.99 (1.63–2.43)**1.66 (1.35–2.04)**
    Quartile 42.52 (2.04–3.11)**2.05 (1.65–2.56)**
Incidence of CHD
    Quartile 1ReferentReferent
    Quartile 21.50 (1.18–1.90)**1.34 (1.05–1.71)*
    Quartile 32.17 (1.72–2.74)**1.76 (1.38–2.24)**
    Quartile 42.8 (2.20–3.60)**2.22 (1.72–2.87)**
  • a Values were calculated with the use of multivariable Cox regression analysis. Data were adjusted for a, age and sex; and b, age, sex, diabetes, BMI, hypertension medication, systolic blood pressure, smoking, log CRP, log creatinine, cholesterol, HDL cholesterol, log triglycerides, and statin medication. Values for hs-cTnI, quartile 1, 1.2–4.4 ng/L; quartile 2, 4.5–6.3 ng/L; quartile 3, 6.4–10.5 ng/L; quartile 4, 10.6–1692 ng/L.

  • b *, P <0.05; **, P <0.001.